Education
About Us
Working with TipRanks
Follow Us
OrthoPediatrics Corp (KIDS)
NASDAQ:KIDS
Total Valuation
OrthoPediatrics has a market cap or net worth of $571.87M. The enterprise value is $626.52M.
Market Cap$571.87M
Enterprise Value$626.52M
Share Statistics
OrthoPediatrics has 24.83M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24.83M
Owened by Insiders32.36%
Owened by Instutions25.60%
Financial Efficiency
OrthoPediatrics’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is -6.06%.
Return on Equity (ROE)-10.67%
Return on Assets (ROA)-7.99%
Return on Invested Capital (ROIC)-6.06%
Return on Capital Employed (ROCE)-6.72%
Revenue Per Employee$364,282.918
Profits Per Employee-$67,298.932
Employee Count562
Asset Turnover0.43
Inventory Turnover0.48
Valuation Ratios
The current PE Ratio of OrthoPediatrics is -14.14. OrthoPediatrics’s PEG ratio is -0.18.
PE Ratio-14.14
PS Ratio2.61
PB Ratio1.51
Price to Fair Value1.51
Price to FCF-12.95
Price to Operating Cash Flow-19.78
PEG Ratio-0.18
Income Statement
In the last 12 months, OrthoPediatrics had revenue of $204.73M and earned -$37.82M in profits. Earnings per share was $0.00.
Revenue$204.73M
Gross Profit$138.79M
Operating Income-$29.52M
Pretax Income-$41.93M
Net Income-$37.82M
EBITDA-10.46M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -$27.39M and capital expenditures -$14.26M, giving a free cash flow of -$41.65M billion.
Operating Cash Flow-$27.39M
Free Cash Flow-$41.65M
Free Cash Flow per Share-$1.68
Dividends & Yields
OrthoPediatrics pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-7.72%
Earnings Yield-7.07%
Stock Price Statistics
Beta1.05
52-Week Price Change-31.20%
50-Day Moving Average24.33
200-Day Moving Average26.63
Relative Strength Index (RSI)53.00
Average Volume (3m)211.21K
Important Dates
OrthoPediatrics upcoming earnings date is Apr 30, 2025, After Close.
Last Earnings DateMar 4, 2025
Next Earnings DateApr 30, 2025
Ex-Dividend Date―
Financial Position
OrthoPediatrics as a current ratio of 6.98, with Debt / Equity ratio of 0.07
Current Ratio6.98
Quick Ratio3.54
Debt to Market Cap0.05
Net Debt to EBITDA1.89
Interest Coverage Ratio-11.26
Taxes
In the past 12 months, OrthoPediatrics has paid -$4.11M in taxes.
Income Tax-$4.11M
Effective Tax Rate9.80%
Enterprise Valuation
OrthoPediatrics EV to EBITDA ratio is -49.35, with an EV/FCF ratio of -12.47.
EV to Sales2.52
EV to EBITDA-49.35
EV to Free Cash Flow-12.47
EV to Operating Cash Flow-19.05
Balance Sheet
OrthoPediatrics has $68.83M in cash and marketable securities with $24.12M in debt, giving a net cash position of -$44.72M billion.
Cash & Marketable Securities$68.83M
Total Debt$24.12M
Net Cash-$44.72M
Net Cash Per Share-$1.80
Tangible Book Value Per Share$8.51
Margins
Gross margin is 72.58%, with operating margin of -14.42%, and net profit margin of -18.47%.
Gross Margin72.58%
Operating Margin-14.42%
Pretax Margin-20.48%
Net Profit Margin-18.47%
EBITDA Margin-5.10%
EBIT Margin-14.42%
Analyst Forecast
The average price target for OrthoPediatrics is $38.71, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$38.71
Price Target Upside80.97%
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast37.65%
EPS Growth Forecast-77.01%